XML 136 R99.htm IDEA: XBRL DOCUMENT
v3.21.2

Summary of Significant Accounting Policies - Summary of significant percentage of total sales (Detail) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018
Supplier A [Member] | Supplier Concentration Risk [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Accounts Payable | $ 2,983 | $ 3,586 |
Supplier A [Member] | Supplier Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 26.00% | 20.00% | 12.00%
Supplier B [Member] | Supplier Concentration Risk [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Accounts Payable | $ 471 | $ 697 |
Supplier B [Member] | Supplier Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 17.00% | 19.00% | 17.00%
Supplier C [Member] | Supplier Concentration Risk [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Accounts Payable | $ 1,000 | $ 360 |
Supplier C [Member] | Supplier Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 10.00% | 15.00% | 20.00%
Product A [Member] | Product Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 27.00% | 30.00% | 38.00%
Product B [Member] | Product Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 26.00% | 20.00% | 12.00%
Product C [Member] | Product Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 17.00% | 19.00% | 17.00%
Product D [Member] | Product Concentration Risk [Member] | Revenue Benchmark [Member] | Bio Ventus LLC |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk, Percentage | 10.00% | 15.00% | 20.00%

X
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.15(a)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15(5)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 + Details
Name: | us-gaap_AccountsPayableCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_SupplierAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=bvs_BioventusIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_SupplierBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_SupplierCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_ProductAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_ProductBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_ProductCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | bvs_ConcentrationRiskBySupplierNameAxis=bvs_ProductDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |